Anomalous left main coronary artery: case series of different courses and literature review
Adam T Marler1, Jamil A Malik1, Ahmad M Slim1
1Cardiology Service, San Antonio Military Medical Center, Fort Sam Houston, TX 78234, USA.
Insights
Congenital coronary artery anomalies, including anomalous origination from the opposite sinus of Valsalva (ACAOS), may pose less risk of sudden cardiac death than previously thought. Further research is needed to determine the true prevalence and risks associated with these cardiac variations.
Area of Science:
- Cardiology
- Congenital Heart Disease
- Cardiac Imaging
Background:
- Congenital coronary artery anomalies are linked to sudden cardiac death.
- Anomalous origination of a coronary artery from an opposite sinus of Valsalva (ACAOS) is a significant area of debate.
- The prevalence and risk associated with these anomalies are not fully understood.
Purpose of the Study:
- To present a case series of anomalous origination of the left coronary artery from the right sinus of Valsalva (L-ACAOS).
- To review the literature regarding the risks of congenital coronary anomalies.
- To discuss the current understanding of ACAOS and its management.
Main Methods:
- Case series presentation of three patients with L-ACAOS.
- Cardiac computed tomography (CT) for coronary anatomy evaluation.
- Functional testing for risk assessment.
Main Results:
- Three cases of L-ACAOS were identified within a short period.
- Despite high-risk features in two cases, medical management led to no symptom recurrence.
- Literature review suggests the risk of sudden cardiac death may be overestimated.
Conclusions:
- The risk of sudden cardiac death from congenital coronary anomalies, including high-risk variants, might be overestimated.
- The prevalence of coronary anomalies is likely underestimated.
- A national registry using cardiac CT and angiography could improve understanding.
- Risk-benefit analysis of surgical intervention versus medical management is crucial.
Abstract:
Background. Congenital anomalies of the coronary arteries are a cause of sudden cardiac death. Of the known anatomic variants, anomalous origination of a coronary artery from an opposite sinus of Valsalva (ACAOS) remains the main focus of debate. Case Series. We present three cases, all presenting to our facility within one week's time, of patients with newly discovered anomalous origination of the left coronary artery from the right sinus of Valsalva (L-ACAOS). All patients underwent cardiac computed tomography for evaluation of coronary anatomy along with other forms of functional testing. Despite the high risk nature of two of the anomalies, the patients are being treated medically without recurrence of symptoms. Summary. After review of the literature, we have found that the risk of sudden cardiac death in patients with congenital coronary anomalies, even among variants considered the highest risk, may be overestimated. In addition, the exact prevalence of coronary anomalies in the general population is currently underestimated. A national coronary artery anomaly registry based on cardiac computed tomography and invasive coronary angiography data would be helpful in advancing our understanding of these cardiac peculiarities. The true prevalence of congenital coronary anomalies and overall risk of sudden cardiac death in this population are not well known. Surgical intervention remains the mainstay of therapy in certain patients though recent investigations into the pathophysiology of these abnormalities have shown that the risk of surgery may outweigh the minimal reduction in risk of sudden cardiac death.
Related Concept Videos
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Cardiac Catheterization III: Left Heart Catheterization
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy


